 Shalini Tayal
Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Microscopic | 1 | 2013 | 4 | 0.390 |
Why?
| | Cryosurgery | 1 | 2014 | 46 | 0.390 |
Why?
| | Duodenal Ulcer | 1 | 2012 | 12 | 0.370 |
Why?
| | Kidney Neoplasms | 2 | 2014 | 413 | 0.370 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2012 | 130 | 0.340 |
Why?
| | Carcinoma, Renal Cell | 1 | 2014 | 230 | 0.340 |
Why?
| | Gastritis | 1 | 2012 | 116 | 0.340 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2012 | 237 | 0.330 |
Why?
| | Cytomegalovirus Infections | 1 | 2012 | 206 | 0.320 |
Why?
| | Proto-Oncogene Proteins c-kit | 2 | 2006 | 72 | 0.270 |
Why?
| | Liposarcoma | 1 | 2005 | 31 | 0.220 |
Why?
| | Sarcoma, Endometrial Stromal | 1 | 2004 | 7 | 0.220 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2006 | 98 | 0.220 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2004 | 58 | 0.210 |
Why?
| | Breast Diseases | 1 | 2003 | 23 | 0.200 |
Why?
| | Uterine Neoplasms | 1 | 2004 | 98 | 0.200 |
Why?
| | Endometrial Neoplasms | 1 | 2004 | 205 | 0.180 |
Why?
| | Biopsy | 2 | 2014 | 1082 | 0.150 |
Why?
| | Biomarkers, Tumor | 1 | 2004 | 1321 | 0.130 |
Why?
| | Adenocarcinoma | 1 | 2004 | 925 | 0.130 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1716 | 0.120 |
Why?
| | Hypertension, Pulmonary | 1 | 2006 | 1957 | 0.110 |
Why?
| | Freezing | 1 | 2014 | 83 | 0.100 |
Why?
| | Brachial Plexus | 2 | 2007 | 34 | 0.080 |
Why?
| | Middle Aged | 7 | 2014 | 36215 | 0.070 |
Why?
| | Fibromatosis, Abdominal | 1 | 2007 | 3 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2014 | 8333 | 0.060 |
Why?
| | Exons | 2 | 2006 | 363 | 0.060 |
Why?
| | Peripheral Nervous System Neoplasms | 1 | 2006 | 19 | 0.060 |
Why?
| | Brachial Plexus Neuropathies | 1 | 2006 | 18 | 0.060 |
Why?
| | Kidney | 1 | 2014 | 1497 | 0.060 |
Why?
| | Humans | 11 | 2014 | 145474 | 0.060 |
Why?
| | Polymerase Chain Reaction | 2 | 2006 | 1041 | 0.060 |
Why?
| | Fatal Outcome | 1 | 2006 | 305 | 0.060 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2005 | 28 | 0.060 |
Why?
| | DNA Mutational Analysis | 1 | 2006 | 407 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 234 | 0.050 |
Why?
| | Endotoxins | 1 | 2004 | 217 | 0.050 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2003 | 61 | 0.050 |
Why?
| | Skin Diseases, Vesiculobullous | 1 | 2003 | 17 | 0.050 |
Why?
| | Mastectomy, Segmental | 1 | 2003 | 107 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2003 | 185 | 0.050 |
Why?
| | Hyperplasia | 1 | 2003 | 177 | 0.050 |
Why?
| | Adult | 5 | 2014 | 40777 | 0.050 |
Why?
| | Diagnosis, Differential | 2 | 2004 | 1508 | 0.050 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2003 | 37 | 0.050 |
Why?
| | Medical Records | 1 | 2003 | 192 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2014 | 17291 | 0.050 |
Why?
| | Vancomycin | 1 | 2003 | 94 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2005 | 777 | 0.040 |
Why?
| | Aged | 4 | 2014 | 26153 | 0.040 |
Why?
| | Female | 6 | 2007 | 78844 | 0.030 |
Why?
| | Male | 7 | 2014 | 72842 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2005 | 2046 | 0.030 |
Why?
| | Incidence | 1 | 2003 | 2923 | 0.030 |
Why?
| | Acute Kidney Injury | 1 | 2004 | 875 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 7123 | 0.020 |
Why?
| | Colorado | 1 | 2003 | 4553 | 0.020 |
Why?
| | Nephrectomy | 1 | 2014 | 163 | 0.020 |
Why?
| | Lung | 1 | 2006 | 4106 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2003 | 1923 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2003 | 2382 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 481 | 0.020 |
Why?
| | Base Pair Mismatch | 1 | 2006 | 10 | 0.020 |
Why?
| | Imatinib Mesylate | 1 | 2006 | 77 | 0.010 |
Why?
| | Benzamides | 1 | 2006 | 226 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2006 | 423 | 0.010 |
Why?
| | Renal Circulation | 1 | 2004 | 75 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2004 | 162 | 0.010 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2004 | 203 | 0.010 |
Why?
| | Sodium | 1 | 2004 | 198 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2769 | 0.010 |
Why?
| | Piperazines | 1 | 2006 | 375 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2006 | 1266 | 0.010 |
Why?
| | Reoperation | 1 | 2006 | 633 | 0.010 |
Why?
| | Creatinine | 1 | 2004 | 515 | 0.010 |
Why?
| | Pyrimidines | 1 | 2006 | 530 | 0.010 |
Why?
| | Immunoglobulin A | 1 | 2003 | 214 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2004 | 858 | 0.010 |
Why?
| | Glomerular Filtration Rate | 1 | 2004 | 765 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2004 | 892 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2006 | 1149 | 0.010 |
Why?
| | Staphylococcal Infections | 1 | 2003 | 391 | 0.010 |
Why?
| | Blood Pressure | 1 | 2004 | 1779 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2004 | 3124 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2004 | 5983 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 11772 | 0.010 |
Why?
| | Mice | 1 | 2004 | 18329 | 0.000 |
Why?
| | Animals | 1 | 2004 | 38030 | 0.000 |
Why?
|
|
Tayal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|